All yearsUpcoming events202420232022202120202019201820172016All years November 22, 2016 Interim Report Q3 2016 Add to calendar February 27, 2017 Year End Report 2016 Add to calendar March 22, 2017 Stockholm Corporate Finance Life Science Seminar Add to calendar April 27, 2017 Annual Report 2016 Add to calendar April 27, 2017 Redeye Biotech Seminar Add to calendar May 30, 2017 Interim Report Q1 2017 Add to calendar May 30, 2017 Annual General Meeting 2017 Add to calendar June 12, 2017 Småbolagsdagen Add to calendar August 25, 2017 Interim Report Q2 2017 Add to calendar September 14, 2017 Nordic Life Science Days Add to calendar November 17, 2017 Interim Report Q3 2017 Add to calendar November 24, 2017 Redeye Life Science Seminar 2017 Add to calendar February 26, 2018 Year-end Report 2017 Add to calendar March 7, 2018 Stockholm Corporate Finance Life Science Seminar Add to calendar April 24, 2018 Annual Report 2017 Add to calendar April 25, 2018 Capital Markets Day Add to calendar May 17, 2018 Interim Report Q1 2018 Add to calendar May 24, 2018 Annual General Meeting 2018 Add to calendar August 28, 2018 Interim Report Q2 2018 Add to calendar September 6, 2018 Pareto Securities Health Care Conference Add to calendar November 19, 2018 Interim Report Q3 2018 Add to calendar November 21, 2018 Redeye Life Science Seminar Add to calendar November 27, 2018 Investor meeting in Copenhagen, Økonomisk Ugebrev Biotech: Kvartalskonference Q4 2018 Add to calendar December 3, 2018 Investor After Work Gothenburg Add to calendar February 20, 2019 Year-end Report 2018 Add to calendar March 27, 2019 Stifel Nordic Healthcare Seminar, London Add to calendar May 6, 2019 Interim Report Q1 2019 Add to calendar May 6, 2019 Annual General Meeting 2019 Add to calendar May 27, 2019 Introduce Investor Days Add to calendar June 10, 2019 Redeye Growth Day Add to calendar August 15, 2019 Interim Report Q2 2019 Add to calendar August 27, 2019 10:00 CET Webcasted presentation of CONDUCT top line results Add to calendar September 5, 2019 Pareto Securities’ 10th annual Health Care Conference Add to calendar October 24, 2019 Redeye Investor After Work in Gothenburg Add to calendar November 19, 2019 Redeye Life Science Day 2019 Add to calendar November 19, 2019 Avanza Börsdag Add to calendar November 27, 2019 Interim Report Q3 2019 Add to calendar December 12, 2019 Investor presentation at Redeye Add to calendar January 22, 2020 Presentation at SEB Biotech & Pharma Seminar Add to calendar February 20, 2020 Interim report Q4 Add to calendar February 20, 2020 Conference call for investors, analysts and media Add to calendar March 3, 2020 Presentation at Carnegie Healthcare Seminar Add to calendar March 30, 2020 Annual Report Add to calendar April 20, 2020 Annual General Meeting Add to calendar May 7, 2020 Interim report Q1 Add to calendar June 2, 2020 Redeye Growth Day 2020 Add to calendar August 26, 2020 Interim report Q2 Add to calendar September 2, 2020 Pareto Securities Healthcare Conference Add to calendar September 24, 2020 Erik Penser Bolagsdag Add to calendar November 25, 2020 Interim report Q3 Add to calendar November 26, 2020 Redeye Life Science Day Add to calendar December 8, 2020 InDex Pharmaceuticals’ virtual R&D day Add to calendar January 12, 2021 Extraordinary General Meeting Add to calendar February 25, 2021 Year-end Report 2020 Add to calendar March 11, 2021 Barclays Global Healthcare Conference Add to calendar March 12, 2021 Carnegie Nordic Virtual Healthcare Seminar 2021 Add to calendar April 23, 2021 Annual Report 2020 Add to calendar May 5, 2021 Interim report Q1 2021 Add to calendar May 6, 2021 Presentation at Erik Penser Bank’s Theme Day – Commercialization of Medicines Add to calendar June 2, 2021 08:50 CET CEO Peter Zerhouni presents at Redeye Growth Day at 08:50 Add to calendar June 3, 2021 Annual General Meeting 2021 Add to calendar August 25, 2021 Interim report Q2 2021 Add to calendar September 2, 2021 CEO Peter Zerhouni presents at Pareto Securities’ Healthcare Conference 2021 Add to calendar September 29, 2021 CEO Peter Zerhouni presents at Naventus Life Science Summit Add to calendar October 7, 2021 CEO Peter Zerhouni will present at HC Andersen Capital Small & Mid Cap Seminar 2021 Add to calendar November 11, 2021 CEO Peter Zerhouni will present at Redeye Life Science Day 2021 Add to calendar November 24, 2021 Interim report Q3 2021 Add to calendar November 24, 2021 CEO Peter Zerhouni & CMO Thomas Knittel present at HC Andersen Capital’s online event Add to calendar November 25, 2021 CEO Peter Zerhouni will present at Erik Penser Banks Bolagsdag Add to calendar December 9, 2021 Presentation at HC Andersen Capital’s Virtual Growth Days seminar Add to calendar January 27, 2022 12:00 CET Deep dive presentation of the design of the phase III study CONCLUDE at HC Andersen Capital’s online event Add to calendar February 23, 2022 Year-end Report 2021 Add to calendar February 24, 2022 Deep dive into the mechanism of action of cobitolimod at HC Andersen Capital’s online event Add to calendar March 31, 2022 Presentation at Redeye Investor Forum in Malmö Add to calendar April 8, 2022 Annual Report 2021 Add to calendar May 16, 2022 Interim Report Q1 2022 Add to calendar June 1, 2022 Annual General Meeting 2022 Add to calendar June 2, 2022 Presentation at Redeye Growth Day Add to calendar June 9, 2022 Deep dive presentation: commercialisation strategy for cobitolimod at HC Andersen Capital’s online event Add to calendar August 26, 2022 Interim Report Q2 2022 Add to calendar September 7, 2022 Presentation at Pareto Securities Healthcare Conference Add to calendar September 22, 2022 Presentation and Q&A – the positive feedback from PMDA by acting CEO Johan Giléus and CMO Anders Bröijersen at HC Andersen Capital Add to calendar October 6, 2022 Presentation at Redeye investor AW in Gothenburg Add to calendar October 8 - October 11, 2022 InDex Pharmaceuticals to exhibit at UEGW Add to calendar November 23, 2022 Interim Report Q3 2022 Add to calendar November 24, 2022 Presentation at Redeye Life Science Day 2022 Add to calendar February 23, 2023 Year-end Report 2022 Add to calendar March 14, 2023 Presentation at Carnegie Healthcare Seminar Add to calendar March 28, 2023 Presentation at HC Andersen Capital- Update on the results of the PK-study with cobitolimod Add to calendar April 12, 2023 Annual Report 2022 Add to calendar April 20, 2023 Presentation at Redeye Investor Forum Göteborg Add to calendar May 9, 2023 Business update with InDex’s managment team at Redeye Add to calendar May 24, 2023 Interim Report Q1 2023 Add to calendar May 24, 2023 Annual General Meeting 2023 Add to calendar June 1, 2023 Presentation at Redeye Growth Day Add to calendar August 23, 2023 Interim Report Q2 2023 Add to calendar August 31, 2023 Presentation at HC Andersen Capital’s Life Science Seminar Add to calendar September 24 - September 26, 2023 InDex is attending the HBM Biopharma Summit Add to calendar October 3, 2023 Presentation at Redeye Theme: Autoimmune and inflammatory disease Add to calendar October 10, 2023 InDex is attending Industrifonden Venture Summit Add to calendar November 28, 2023 Interim Report Q3 2023 Add to calendar February 21, 2024 Year-end Report 2023 Add to calendar
November 27, 2018 Investor meeting in Copenhagen, Økonomisk Ugebrev Biotech: Kvartalskonference Q4 2018 Add to calendar
May 6, 2021 Presentation at Erik Penser Bank’s Theme Day – Commercialization of Medicines Add to calendar
September 2, 2021 CEO Peter Zerhouni presents at Pareto Securities’ Healthcare Conference 2021 Add to calendar
October 7, 2021 CEO Peter Zerhouni will present at HC Andersen Capital Small & Mid Cap Seminar 2021 Add to calendar
November 24, 2021 CEO Peter Zerhouni & CMO Thomas Knittel present at HC Andersen Capital’s online event Add to calendar
January 27, 2022 12:00 CET Deep dive presentation of the design of the phase III study CONCLUDE at HC Andersen Capital’s online event Add to calendar
February 24, 2022 Deep dive into the mechanism of action of cobitolimod at HC Andersen Capital’s online event Add to calendar
June 9, 2022 Deep dive presentation: commercialisation strategy for cobitolimod at HC Andersen Capital’s online event Add to calendar
September 22, 2022 Presentation and Q&A – the positive feedback from PMDA by acting CEO Johan Giléus and CMO Anders Bröijersen at HC Andersen Capital Add to calendar
March 28, 2023 Presentation at HC Andersen Capital- Update on the results of the PK-study with cobitolimod Add to calendar